costs
drug discovery
labelled carbon dioxide
radiolabelling Absorption
radiolabelling of drugs
C-labelled version
development
carboxylic acids
s studies
LABEL-DIOX
execution of preclinical studies
late-stage carboxylation event
C-labelled building blocks
current radiolabelling syntheses
lengthy radiolabelled synthesis
lengthy-step sequences
Late-stage catalytic carboxylation techniques
carbon isotope incorporation
invaluable preclinical data
new opportunities
distribution
excretion
myriad of agrochemicals
privileged motifs
metabolism
ADME
overall efficiency
earth-abundant catalysts
way industrial chemists
moisture sensitive
labeled CO2
revenues
pharmaceuticals
consideration
opportunity
waste disposal
components
air
mild conditions
design
protocol
living organisms
research
present
decision